Cyanotech Co. (OTCMKTS:CYAN – Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 2,938 shares, a growth of 2,477.2% from the June 30th total of 114 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 3,344 shares, the short-interest ratio is currently 0.9 days.
Cyanotech Stock Performance
Shares of CYAN remained flat at $0.53 during mid-day trading on Friday. Cyanotech has a 1 year low of $0.21 and a 1 year high of $0.57. The company has a quick ratio of 0.42, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm’s 50 day simple moving average is $0.48 and its 200 day simple moving average is $0.42. The stock has a market capitalization of $3.91 million, a price-to-earnings ratio of -2.12 and a beta of 0.12.
Cyanotech (OTCMKTS:CYAN – Get Free Report) last issued its quarterly earnings results on Monday, June 29th. The biotechnology company reported $0.00 earnings per share for the quarter. Cyanotech had a negative net margin of 4.82% and a negative return on equity of 16.24%.
Cyanotech Company Profile
Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.
Featured Stories
- Five stocks we like better than Cyanotech
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.
